Spots Global Cancer Trial Database for tumor vaccine

Every month we try and update this database with for tumor vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Derivation of Tumor Specific Hybridomas	NCT01702792	Glioblastoma	Tumor Vaccine	18 Years -	Dartmouth-Hitchcock Medical Center
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma	NCT00459069	Multiple Myelom...	Dendritic Cell ...	18 Years -	Dana-Farber Cancer Institute
An Individualized Anti-Cancer Vaccine Study in Patients With HCC	NCT01995227	Hepatocellular ...	AlloVax CRCL AlloStim	18 Years -	Immunovative Therapies, Ltd.
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas	NCT00751270	Malignant Gliom... Glioblastoma Mu... Anaplastic Astr...	AdV-tk Valacyclovir	18 Years -	Candel Therapeutics, Inc.
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma	NCT00589875	Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio...	CAN-2409 Valacyclovir Temozolomide Radiation thera...	18 Years -	Candel Therapeutics, Inc.
Tumor Vaccines for Solid Tumors	NCT06102837	Glioma Solid Tumor	tumor vaccine Radiotherapy Chemotherapy Surgery	-	Huashan Hospital
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma	NCT00459069	Multiple Myelom...	Dendritic Cell ...	18 Years -	Dana-Farber Cancer Institute
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer	NCT03908671	Esophageal Canc... Non Small Cell ...	Personalized mR...	18 Years - 75 Years	Stemirna Therapeutics
Derivation of Tumor Specific Hybridomas	NCT01702792	Glioblastoma	Tumor Vaccine	18 Years -	Dartmouth-Hitchcock Medical Center
NV-001 in the Treatment of Advanced Solid Tumors	NCT06051760	Malignant Neopl...	NV-001	18 Years - 75 Years	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas	NCT00751270	Malignant Gliom... Glioblastoma Mu... Anaplastic Astr...	AdV-tk Valacyclovir	18 Years -	Candel Therapeutics, Inc.
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas	NCT00751270	Malignant Gliom... Glioblastoma Mu... Anaplastic Astr...	AdV-tk Valacyclovir	18 Years -	Candel Therapeutics, Inc.
A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors	NCT05747339	Solid Tumors, A...	tumor treatment...	18 Years - 75 Years	Wuxi People's Hospital
The Role of B7-H4 in Tumor Vaccine	NCT06156150	Glioma	tumor vaccine	18 Years - 80 Years	Huashan Hospital
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas	NCT00001564	Ewing's Sarcoma Rhabdomyosarcom...	EF-1 Peptide EF-2 Peptide PXFK Peptide E7 Peptide IL-2 IL-4 GM-CSF CD40 Ligand	- 30 Years	National Institutes of Health Clinical Center (CC)
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation	NCT00405327	Sarcoma Neuroblastoma Wilm's Tumor	Tumor lysate-pu... Hematopoietic s...	- 30 Years	University of Michigan Rogel Cancer Center
Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer	NCT01433172	Lung Cancer Adenocarcinoma	Phase I - GM.CD... Phase II - GM.C... Phase II - GM.C...	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer	NCT00045968	Glioblastoma Mu... Glioblastoma GBM Grade IV Astroc... Glioma Brain Cancer Brain Tumor	Dendritic cell ...	18 Years - 70 Years	Northwest Biotherapeutics
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma	NCT00589875	Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio...	CAN-2409 Valacyclovir Temozolomide Radiation thera...	18 Years -	Candel Therapeutics, Inc.
Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck	NCT01998542	Cancer of Head ... Squamous Cell C...	AlloVax CRCL AlloStim	18 Years - 70 Years	Immunovative Therapies, Ltd.
Dendritic Cells in Lung Cancer	NCT00442754	Non Small Cell ...	Allogeneic Tumo...	18 Years -	Herlev Hospital
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas	NCT00001566	Ewing's Sarcoma Rhabdomyosarcom...	therapeutic aut... indinavir sulfa... peripheral bloo...	5 Years - 35 Years	National Institutes of Health Clinical Center (CC)
Suicide Plus Immune Gene Therapy for Advanced Melanoma	NCT03338777	Melanoma	Suicide plus im...	18 Years -	Hospital Italiano de Buenos Aires
Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck	NCT01998542	Cancer of Head ... Squamous Cell C...	AlloVax CRCL AlloStim	18 Years - 70 Years	Immunovative Therapies, Ltd.
A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors	NCT05747339	Solid Tumors, A...	tumor treatment...	18 Years - 75 Years	Wuxi People's Hospital
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)	NCT00638612	Pancreatic Aden... Pancreatic Canc...	AdV-tk Valacyclovir	18 Years -	Candel Therapeutics, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: